The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Influenza Vaccines Market Expected To Change Between 2026 And 2030?
The influenza vaccines market size has experienced significant growth in recent years. It is forecast to expand from $9.04 billion in 2025 to $9.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The historical increase in the market can be attributed to the rising prevalence of seasonal influenza, limited public awareness in early 2000s, predominance of trivalent vaccines, low global manufacturing capacity, and reliance on traditional egg-based production methods.
The influenza vaccines market size is projected to experience substantial expansion over the upcoming years, reaching $13.13 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.8%. This anticipated growth during the forecast period can be primarily attributed to factors such as the rising uptake of quadrivalent vaccines, the broadening of precision medicine strategies, increasing governmental vaccination programs, advancements in cell-based and recombinant vaccine development, and improvements in cold chain and distribution networks. Key trends expected during the forecast period encompass the optimization of seasonal vaccine formulations, the broadening of pediatric immunization initiatives, a rise in government-backed flu vaccination campaigns, the integration of new adjuvants to boost immunogenicity, and an expansion of vaccine delivery services in home and outpatient settings.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp
Which Major Factors Are Driving The Expansion Of The Influenza Vaccines Market?
The increasing occurrence of seasonal influenza is anticipated to drive forward the influenza vaccine market. Seasonal influenza is characterized as a respiratory ailment triggered by influenza viruses, which commonly circulate and lead to infections during specific periods annually, typically in colder months. This trend stems from factors such as antigenic drift, population susceptibility, environmental elements, insufficient vaccine coverage, and a lack of widespread immunization. Influenza vaccines are instrumental in decreasing seasonal influenza cases by offering protection against the prevailing virus strains. For instance, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, disclosed that the 2022-2023 flu season saw approximately 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths. Consequently, the rising instances of seasonal influenza are fueling the expansion of the influenza vaccine market.
How Is The Influenza Vaccines Market Structured Across Different Segments?
The influenza vaccines market covered in this report is segmented –
1) By Vaccine Type: Inactivated, Live Attenuated
2) By Valency: Quadrivalent, Trivalent
3) By Route Of Administration: Injection, Nasal Spray
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels
Subsegments:
1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)
2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)
Which Trends Are Shaping The Future Of The Influenza Vaccines Market?
Leading companies operating within the influenza vaccine market are adopting advanced product innovations, such as quadrivalent seasonal influenza vaccines, to strengthen their respiratory vaccine franchise and financial profile. A quadrivalent seasonal influenza vaccine is engineered to protect against four distinct flu viruses, encompassing two influenza A viruses and two influenza B viruses. For instance, in September 2023, Clover Biopharmaceuticals Ltd., a biotechnology company based in China, launched AdimFlu-S (QIS), a quadrivalent seasonal influenza vaccine. This particular vaccine stands as the only imported quadrivalent seasonal influenza vaccine approved for use in individuals aged three years and older across China. The quadrivalent composition of the vaccine enhances its capability to achieve high vaccine effectiveness, regardless of which influenza B strain becomes seasonally prevalent, when compared with trivalent options.
Which Major Players Dominate The Influenza Vaccines Market?
Major companies operating in the influenza vaccines market are Pfizer Inc., Merck & Co Inc., Sanofi-Aventis LLC, GlaxoSmithKline plc, Serum Institute of India Private Limited, Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shionogi & Co Ltd., Sinovac Biotech Co Ltd., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc., China National Pharmaceutical Group Corporation, Green Cross Corporation, Mitsubishi Tanabe Pharma Corporation, Osivax, Vaxess Technologies Inc., Gamma Vaccines Pty Ltd
Read the full influenza vaccines market report here:
https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report
Which Region Currently Holds The Largest Share Of The Influenza Vaccines Market?
North America was the largest region in the influenza vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Influenza Vaccines Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp
Browse Through More Reports Similar to the Global Influenza Vaccines Market 2026, By The Business Research Company
Influenza Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report
Influenza Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model